VACC
Vaccitech Plc
$3.09
Earnings Summary
Revenue | $0.33Mn |
Net Profits | $-23.8Mn |
Net Profit Margins | -7126.35% |
Highlights
Vaccitech Plc’s revenue fell -98.04% since last year same period to $0.33Mn in the Q2 2023. On a quarterly growth basis, Vaccitech Plc has generated -28.63% fall in its revenue since last 3-months.
Vaccitech Plc’s net profit fell -251.67% since last year same period to $-23.8Mn in the Q2 2023. On a quarterly growth basis, Vaccitech Plc has generated -30.92% fall in its net profits since last 3-months.
Vaccitech Plc’s net profit margin fell -7848.48% since last year same period to -7126.35% in the Q2 2023. On a quarterly growth basis, Vaccitech Plc has generated -83.45% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Vaccitech Plc post its latest quarter earnings
EPS Estimate Current Quarter | -0.57 |
EPS Estimate Current Year | -0.57 |
Highlights
Vaccitech Plc’s earning per share (EPS) estimates for the current quarter stand at -0.57 - a -8.79% fall from last quarter’s estimates.
Vaccitech Plc’s earning per share (EPS) estimates for the current year stand at -0.57.
Key Ratios
Key ratios of the Vaccitech Plc post its Q3 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Vaccitech Plc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2023. This indicates that the Vaccitech Plc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-10 | -0.52 | 0 | 100% |
2023-11-09 | -0.57 | 0 | 100% |
₹0 US Stocks a/c Opening Fee